THIS NOVEL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain cancer known for its fast growth and insensitivity to typical treatments. Investigations are constantly underway to identify new therapeutic strategies, and recently, a unique biomarker named LCA168 has emerged as a potential focus for GBM treatment. LCA168 is a protein that is highly expressed in GBM cells compar